The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies

Anti-CD20 monoclonal antibodies (MAbs) have revolutionized the treatment of B-cell leukemia and lymphoma. However, many patients do not respond to such treatment due to either deficiency of the complementary immune response or resistance to apoptosis. Other currently available treatments are often i...

Descripción completa

Detalles Bibliográficos
Autores principales: Markovič, Tijana, Podgornik, Helena, Avsec, Damjan, Nabergoj, Sanja, Mlinarič-Raščan, Irena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835876/
https://www.ncbi.nlm.nih.gov/pubmed/35163524
http://dx.doi.org/10.3390/ijms23031599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835876/
https://www.ncbi.nlm.nih.gov/pubmed/35163524
http://dx.doi.org/10.3390/ijms23031599

Ejemplares similares